Growth Differentiation Factor 15 in Children with Chronic Kidney Disease and after Renal Transplantation

Table 3

Prevalence of cardiovascular risk factors in the Tx cohort and univariate relations to GDF-15.

		(%)	Geometric mean (ng/L)	95% CI	value
Weight	Normal weight	36 (68%)	937	796-1103	0.028; ANOVA
	Overweight	12 (23%)	857	639-1150
	Obesity	5 (9%)	1647	1288-2107
Blood pressure	Hypertension	27 (49%)	967	799-1170	0.981
	No hypertension	26 (51%)	970	794-1186
HDL	<40 mg/dL	11 (21%)	1277	889-1832	0.038
	≥40 mg/dL	41 (79%)	907	786-1047
LDL	>130 mg/dL	5 (9%)	1103	667-1825	0.536
	≤130 mg/dL	48 (91%)	956	828-1103
Cholesterol	>200 mg/dL	9 (17%)	952	821-1104	0.462
	≤200 mg/dL	43 (83%)	1088	718-1646
TG	>150 mg/dL	33 (62%)	1085	914-1288	0.028
	≤150 mg/dL	20 (38%)	803	655-986
Uric acid	Hyperuricemia	22 (42%)	1288	668-938	<0.001
	No hyperuricemia	31 (58%)	792	1096-1512

Two-sided value less than 0.05.